Off‐Label Use of Selective JAK1 Inhibitors in Immune‐Mediated Inflammatory Skin Diseases: A Retrospective Case Series

Documenti analoghi

• JAK Inhibitors for Pemphigoid Diseases
  di: Enkhbilguun Sodbuyan, et al.
  Pubblicazione: (2025)
• JAK Inhibitors as a Novel Approach to Autoimmune Bullous Diseases: A Review
  di: Olga Olisova, et al.
  Pubblicazione: (2026)
• Dupilumab in Combination With JAK Inhibitor for Refractory Moderate‐to‐Severe Atopic Dermatitis
  di: Xiaoting Song, et al.
  Pubblicazione: (2024)
• Comparative Safety Analysis of JAK Inhibitors in the Treatment of Atopic Dermatitis: Based on the FAERS Database
  di: Zijun Song, et al.
  Pubblicazione: (2026)
• Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series
  di: Xiu-kun Sun, et al.
  Pubblicazione: (2024)